Angewandte
Research Articles
Chemie
How to cite:
Total Synthesis
Hot Paper
Asymmetric Total Synthesis of Sarpagine and Koumine Alkaloids
Zhao Yang+, Qiuyuan Tan+, Yan Jiang, Jiaojiao Yang, Xiaojiao Su, Zhen Qiao, Wenqiang Zhou,
Abstract: We report here a concise, collective, and asymmetric
total synthesis of sarpagine alkaloids and biogenetically related
koumine alkaloids, which structurally feature a rigid cage
scaffold, with l-tryptophan as the starting material. Two key
bridged skeleton-forming reactions, namely tandem sequential
oxidative cyclopropanol ring-opening cyclization and ketone
a-allenylation, ensure concurrent assembly of the caged
sarpagine scaffold and installation of requisite derivative
handles. With a common caged intermediate as the branch
point, by taking advantage of ketone and allene groups therein,
total synthesis of five sarpagine alkaloids (affinisine, norma-
cusine B, trinervine, Na-methyl-16-epipericyclivine, and vello-
simine) with various substituents and three koumine alkaloids
(koumine, koumimine, and N-demethylkoumine) with more
complex cage scaffolds has been accomplished.
widely or thoroughly evaluated, probably because of their
natural paucity.[1]
The intriguingly diverse, structurally complex architec-
tures and the biological profiles of above-mentioned alkaloids
inspired our interest. With the objective of developing a new
and efficient strategy that enable collective total synthesis of
both sarpagine[5,6] and koumine[6h,7] alkaloids, ideally from
a common late-stage intermediate, we embarked on a syn-
thetic program toward these two natural product families.
Our synthetic strategy (Scheme 1) involved the synthesis of
sarpagine alkaloids with various substituents, for example,
ester, aldehyde, or alcohol, on C16 together with vinyllidene
or oxygenated ethyl substituents on C20. This could be
achieved using an advanced cage intermediate 1 with versatile
ketone and allene groups at the corresponding positions.
Meanwhile, with intermediate 1 as the branchpoint, the
scaffold of koumine alkaloids could be built by a p-Lewis
Introduction
acid-catalyzed biomimetic indolyl addition to the allene unit
[8]
À
Sarpagine alkaloids belong to the monoterpene indole
alkaloid family, and more than 100 members have been
isolated, mainly from the Apocynaceae (e.g. Alstonia and
Rauvolfia genera) and Gelsemiaceae (e.g. Gelsemium genus)
plant families (some representative members are shown in
Figure 1A).[1] Structurally, sarpagine alkaloids feature a di-
versely substituted, cage-shaped scaffold, which can be
disassembled into two bridged substructures, namely indole-
fused azabicyclo[3.3.1]nonane and azabicyclo[2.2.2]octane
(Figure 1B). Ajmaline (trade name Gilurytmal), which is
a prominent congener of sarpagine alkaloids, has been used as
a diagnostic drug to induce arrhythmic contractions in
patients suspected of having Brugada syndrome (Fig-
ure 1C).[2] Koumine alkaloids, which are biogenetically de-
rived from sarpagine alkaloids,[3] have more complex cage
scaffolds and show a broad spectrum of biological properties,
such as antitumor, antiinflammatory, analgesic, and immuno-
modulatory effects (Figure 1C).[4] However, the potential
biological activities of sarpagine alkaloids have not been
after a C3 N bond breakage. We envisioned that the cage
scaffold of 1 could be assembled by two critical bridged
skeleton-forming steps: 1) ketone a-allenylation to form the
bicyclo[2.2.2]octane moiety, and 2) intramolecular oxidative
cyclopropanol cyclization to form the bicyclo[3.3.1]nonane
moiety. The bicyclo[2.2.2]octane moiety is most commonly
constructed by a-vinylation of a ketone via a palladium-
catalyzed coupling process.[5,6] Instead of a vinyl group
introduction at C20 via this known method, our proposed
strategy installs a more versatile allene group. This would
increase the potential for late-stage structural diversifica-
tions.[9] To access the azabicyclo[3.3.1]nonane motif, seminal
and effective methods such as Dieckmann cyclization,[5] olefin
metathesis,[6a,b] indolyl Friedel–Crafts reaction,[6c,d] and [5+2]-
cycloaddition/ring enlargement,[6e,f] have been developed. We
envisioned that a tandem amine oxidation and cyclopropanol
ring-opening cyclization of substrate 5a would allow rapid
assemble of the azabicyclo[3.3.1]nonane skeleton and intro-
duction of a versatile ketone group.[10] Enantiopure 5a with
a dictating chiral carbon center can be directly synthesized via
Kulinkovich cyclopropanation of a carboxyl ester,[11] which
can be easily derived from the cheap chiral starting material
l-tryptophan.[12]
[*] Z. Yang,[+] Q. Tan,[+] Y. Jiang, J. Yang, X. Su, Z. Qiao, W. Zhou, L. He,
H. Qiu, Prof. Dr. M. Zhang
Chongqing Key Laboratory of Natural Product Synthesis and Drug
Research, Innovative Drug Research Centre, School of Pharmaceut-
ical Sciences, Chongqing University
Results and Discussion
55 Daxuecheng South Road, Shapingba, Chongqing 401331 (China)
E-mail: minzhang@cqu.edu.cn
Bicyclo[3.3.1]nonane Skeleton Construction
[+] These authors contributed equally to this work.
First, We explored the feasibility of constructing the
bicyclo[3.3.1]nonane motif via the proposed tandem amine
oxidation and cyclopropanol ring-opening cyclization (Ta-
Supporting information and the ORCID identification number(s) for
the author(s) of this article can be found under:
&&&&
ꢀ 2021 Wiley-VCH GmbH
Angew. Chem. Int. Ed. 2021, 60, 2 – 9
These are not the final page numbers!